The History and Evolution of Neurovascular Interventions Technology
Disclaimer
This blog post is intended for informational purposes only and should not be considered medical advice. Always consult with a qualified healthcare professional for any medical concerns or before making any decisions related to your health or treatment.
Meta Description
Explore the fascinating history and evolution of neurovascular interventions technology, from early techniques to modern advancements like flow diversion and stent technology. Discover key milestones and future directions in treating cerebrovascular diseases and intracranial aneurysms. Optimized for patients and healthcare professionals.
Introduction
Neurovascular diseases, affecting the brain and spinal cord's blood vessels, represent a significant global health challenge, leading to conditions such as stroke, aneurysms, and arteriovenous malformations. These conditions can result in severe disability or death, underscoring the critical need for effective diagnostic and therapeutic interventions. Over the past century, the field of neurovascular interventions has undergone a remarkable transformation, evolving from rudimentary surgical approaches to highly sophisticated, minimally invasive endovascular techniques. This evolution has been driven by continuous technological innovation, leading to improved patient outcomes and expanded treatment possibilities. This article will delve into the historical development and technological advancements that have shaped neurovascular interventions, highlighting key milestones and future prospects in this dynamic medical specialty.
Early History of Neurointervention: Foundations and Pioneers
The origins of neurovascular intervention can be traced back to the early 20th century with pioneering efforts in neurosurgery. One of the earliest reported surgical treatments for an intracranial aneurysm was performed in 1931 by Norman Dott, who utilized a wrapping technique [6]. However, these open surgical procedures were often associated with significant risks and limitations, particularly for deep-seated or complex lesions. The true dawn of neurointervention as a distinct field began in the 1960s and 1970s with the emergence of endovascular techniques. These early attempts, primarily driven by neurosurgeons and neuroradiologists, focused on treating “inoperable” cerebrovascular lesions [7]. These initial endovascular embolization techniques laid the groundwork for future advancements, demonstrating the potential of catheter-based approaches to access and treat vascular abnormalities within the brain.
Evolution of Endovascular Coiling
The landscape of neurovascular intervention was revolutionized with the introduction of Guglielmi Detachable Coils (GDCs) in the early 1990s. The first intracranial aneurysm was treated using this groundbreaking technology on April 12, 1990 [19]. GDCs, made of platinum, allowed for the precise occlusion of aneurysms by filling the sac with coils, thereby promoting thrombosis and preventing rupture. This innovation marked a significant shift from open surgery to minimally invasive endovascular repair, offering a safer and less invasive alternative for many patients. Subsequent generations of coils, including bioactive coils (e.g., Matrix bioactive coil, HydroCoil embolic system) [26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36] and those with different detachment mechanisms, further improved the efficacy and durability of aneurysm occlusion. The International Subarachnoid Aneurysm Trial (ISAT) in 2002 provided compelling evidence supporting the use of endovascular coiling over neurosurgical clipping for ruptured intracranial aneurysms, further solidifying its role as a primary treatment modality [25].
Advancements in Stent Technology
While coiling proved highly effective for many aneurysms, wide-necked or complex aneurysms often posed challenges, as coils could prolapse into the parent artery. This led to the development of adjunctive techniques, most notably stent-assisted coiling. The introduction of intracranial stents, such as the Neuroform stent (2002) and Enterprise stent (2007), provided a scaffold across the aneurysm neck, allowing for stable coil placement while preserving blood flow in the parent vessel [49, 50, 51, 54]. These early stents, made of nitinol, represented a significant technological leap, enabling the treatment of previously untreatable aneurysms. Further advancements led to the development of more sophisticated stents with improved designs, including closed-cell and braided designs (e.g., LVIS, LVIS Jr, Neuroform Atlas) [199, 200, 201], offering enhanced conformability and navigability within the tortuous neurovasculature. The evolution of stent technology has been crucial in expanding the applicability of endovascular techniques to a broader range of aneurysm morphologies.
The Rise of Flow Diversion Devices
Building upon the principles of stent technology, flow diversion emerged as a paradigm-shifting approach for treating complex and giant aneurysms, particularly those that were not amenable to coiling or stent-assisted coiling. The Pipeline Embolization Device (PED), FDA-approved in 2011, was a pioneering flow diverter [204]. Unlike traditional stents that act as a scaffold for coils, flow diverters are densely braided mesh devices designed to reconstruct the parent artery, diverting blood flow away from the aneurysm sac. This promotes thrombosis within the aneurysm while maintaining patency of the parent vessel and its perforating branches. The subsequent development of devices like the FRED (Flow Re-direction Endoluminal Device) and Surpass Streamline further refined flow diversion technology, offering improved deliverability and expanded treatment options [208, 211]. Flow diversion has significantly reduced the need for complex open surgical procedures for certain types of aneurysms, transforming the treatment landscape for these challenging cases [79, 84, 85, 88, 90].
Liquid Embolics and Other Innovations
Beyond coils, stents, and flow diverters, liquid embolic agents have played a vital role in neurovascular interventions, particularly for the treatment of arteriovenous malformations (AVMs) and fistulas. Agents like Onyx HD-500, approved in 2007, are non-adhesive liquid embolic systems that solidify upon contact with blood, allowing for controlled and complete occlusion of vascular lesions [218, 74, 75, 76, 78]. The development of these agents has provided neurointerventionalists with versatile tools for complex embolization procedures. Other notable innovations include intrasaccular flow disruption devices like the WEB (Woven EndoBridge) device, which offers an alternative to coiling for wide-necked bifurcation aneurysms by creating an intrasaccular flow disruption [223, 66, 105, 106, 107, 109, 110, 111]. Balloon-assisted techniques have also evolved, providing temporary occlusion or remodeling during coiling procedures [225, 226, 227, 228, 229, 230, 231, 232, 233, 234].
Antiplatelet Therapy in Neurointerventions
The increasing use of endovascular devices, particularly stents and flow diverters, has necessitated the careful management of antiplatelet therapy to prevent thrombotic complications. Patients undergoing these procedures often require dual antiplatelet therapy (DAPT) to inhibit platelet aggregation and maintain device patency [114, 115, 116, 117, 120, 121, 122]. The evolution of antiplatelet regimens, including the use of various P2Y12 inhibitors (e.g., clopidogrel, prasugrel, ticagrelor) in combination with aspirin, has been critical in minimizing periprocedural and post-procedural ischemic events. Ongoing research continues to refine antiplatelet strategies, balancing the risk of thrombosis with the risk of hemorrhagic complications, especially in cases of ruptured aneurysms [102, 103, 104].
Future Directions and Emerging Technologies
The field of neurovascular interventions continues to evolve at a rapid pace, driven by ongoing research and technological advancements. Future directions include the development of even more advanced device designs, such as drug-eluting stents and bioresorbable scaffolds, aimed at further improving long-term outcomes and reducing complications. Robotic-assisted neurointerventions are also emerging, promising enhanced precision and reduced radiation exposure for operators [13]. Artificial intelligence (AI) and machine learning are being integrated into image analysis and procedural planning, offering the potential for personalized treatment strategies. Furthermore, advancements in neuroimaging techniques will continue to play a crucial role in guiding interventions and monitoring treatment efficacy. The focus remains on developing safer, more effective, and less invasive treatments for a wider spectrum of neurovascular diseases, ultimately improving the quality of life for patients worldwide.
Conclusion
The history of neurovascular interventions technology is a testament to continuous innovation and dedication to improving patient care. From the rudimentary surgical techniques of the early 20th century to the sophisticated endovascular devices of today, each advancement has brought us closer to safer and more effective treatments for complex cerebrovascular diseases. The evolution of coiling, stent technology, flow diversion, liquid embolics, and adjunctive therapies has transformed the landscape of neurointervention, offering hope to countless patients. As research and technology continue to progress, the future holds even greater promise for further breakthroughs, ultimately leading to better outcomes and a deeper understanding of neurovascular conditions. INVAMED is committed to contributing to this ongoing evolution by providing cutting-edge medical devices that empower healthcare professionals to deliver the best possible care.
References
1. [The History and Development of Endovascular Neurosurgery](https://www.intechopen.com/chapters/75944) 2. [A review of technological innovations leading to modern endovascular brain aneurysm treatment](https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2023.1156887/full) 3. [Key milestones in the field of endovascular interventional therapy.](https://www.researchgate.net/figure/Key-milestones-in-the-field-of-endovascular-interventional-therapy_fig1_367148119) 4. [The pioneering past and cutting-edge future of interventional ... - PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC11569488/) 5. [History of Neurointervention - PubMed](https://pubmed.ncbi.nlm.nih.gov/37549692/) 6. [The Evolution of Endovascular Therapy for Intracranial Aneurysms](https://journals.sagepub.com/doi/10.1177/26331055221117560) 7. [The Continued Evolution of Neurointervention - Endovascular Today](https://evtoday.com/articles/2020-feb/the-continued-evolution-of-neurointervention) 8. [Neurovascular Interventions: Evolving Techniques and Insights](https://www.mdpi.com/journal/jcm/special_issues/IWUBC72J4Z) 9. [Neurovascular surgery: a review of the way forward from the ...](https://asj.amegroups.org/article/view/94806/html) 10. [The Evolution and Future Directions of Endovascular Therapy](https://www.cns.org/Assets/9fc9f4c0-e5dd-4858-bd48-cbf97784594c/636988018853630000/chapter19-2-53-pdf) 11. [Neuroendovascular Intervention Milestones](https://www.acgme.org/globalassets/pdfs/milestones/neuroendovascularinterventionmilestones.pdf) 12. [Key Trends in Neurovascular Intervention for 2024](https://blog.smarttrak.com/key-trends-in-neurovascular-intervention-for-2024) 13. [Neurointervention in the 2020s: Where are We Going?](https://pmc.ncbi.nlm.nih.gov/articles/PMC7485210/) 14. [What You Always Wanted to Know about Endovascular ... - PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC11267361/) 15. [The Holy Grail of Neurointervention: Endovascular Therapy ...](https://pubs.rsna.org/doi/10.1148/radiol.251751) 16. [Journal of Cerebrovascular and Endovascular Neurosurgery](https://www.the-jcen.org/articles/search.php?term=4&key=Surgery) 17. [Top 5 SEO Tips for Vascular Specialists to Boost Their Online ...](https://www.linkedin.com/pulse/top-5-seo-tips-vascular-specialists-boost-online-presence-noor-alam-bergc) 18. [SEO Keywords for Neurologist - Marketkeep](https://marketkeep.com/seo-keywords-for-neurologist/) 19. [Neurosurgery SEO Company | Search Engine Optimization Services](https://www.cardinaldigitalmarketing.com/healthcare-specialties/neurosurgery-agency/seo-company/) 20. [SEO Healthcare Study | Wheelhouse DMG](https://www.wheelhousedmg.com/insights/research/seo-healthcare-study/) 21. [The Guide on Healthcare SEO Keywords in 2026 - Medesk](https://www.medesk.net/en/blog/healthcare-seo-keywords/) 22. [Best Healthcare SEO Keywords for Specialties and Medical Services](https://wiserank.co.uk/best-healthcare-seo-keywords/) 23. [The 100 most‐cited articles about the role of neurovascular unit in ...](https://pmc.ncbi.nlm.nih.gov/articles/PMC8193691/) 24. [Neurovascular Medical Devices Market Abbreviations - LinkedIn](https://www.linkedin.com/pulse/neurovascular-medical-devices-market-abbreviations-bd2cf/) 25. [Neurovascular Surgical Devices Industry: How AI, Innovation, and ...](https://www.frost.com/growth-opportunity-news/healthcare/chronic-care/neurovascular-surgical-devices-industry-how-ai-innovation-and-partnerships-are-shaping-the-future-tjstory-cim-sg/) 26. [Neurovascular Imaging Research | Cedars-Sinai](https://www.cedars-sinai.edu/health-sciences-university/research/departments-institutes/biomedical-sciences/biomedical-imaging/neurovascular.html) 27. [MolyneuxAKerrRStrattonISandercockPClarkeMShrimptonJet al. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet. (2002) 360:1267–74. 10.1016/s0140-6736(02)11314-6](https://pubmed.ncbi.nlm.nih.gov/12406212/) 28. [WhitePMRaymondJ. Endovascular coiling of cerebral aneurysms using “bioactive” or coated-coil technologies: a systematic review of the literature. AJNR Am J Neuroradiol. (2009) 30:219–26. 10.3174/ajnr.A1324](https://pubmed.ncbi.nlm.nih.gov/18945869/) 29. [FengLVinuelaFMurayamaY. Healing of intracranial aneurysms with bioactive coils. Neurosurg Clin N Am. (2005) 16:487–99, v–vi. 10.1016/j.nec.2005.03.001](https://pubmed.ncbi.nlm.nih.gov/16039974/) 30. [BendokBRAbi-AadKRWardJDKnissJFKwasnyMJRahmeRJet al. The Hydrogel Endovascular Aneurysm Treatment Trial (HEAT): a randomized controlled trial of the second-generation hydrogel coil. Neurosurgery. (2020) 86:615–24. 10.1093/neuros/nyaa006](https://pubmed.ncbi.nlm.nih.gov/31904832/) 31. [WhitePMLewisSCGholkarASellarRJNahserHCognardCet al. Hydrogel-coated coils versus bare platinum coils for the endovascular treatment of intracranial aneurysms (HELPS): a randomised controlled trial. Lancet. (2011) 377:1655–62. 10.1016/S0140-6736(11)60408-X](https://pubmed.ncbi.nlm.nih.gov/21565620/) 32. [RaymondJKlinkRChagnonMBarnwellSLEvansAJMoccoJet al. Hydrogel versus bare platinum coils in patients with large or recurrent aneurysms prone to recurrence after endovascular treatment: a randomized controlled trial. AJNR Am J Neuroradiol. (2017) 38:432–41. 10.3174/ajnr.A5101](https://pubmed.ncbi.nlm.nih.gov/28007727/) 33. [BrinjikjiW. Leveling up: why are we ignoring Level 1A evidence in favor of HydroCoil?Interv Neuroradiol. (2021) 27:741. 10.1177/15910199211057892](https://pubmed.ncbi.nlm.nih.gov/34784742/) 34. [IshiiAMurayamaYNienY-LYukiIAdaponPHKimRet al. Immediate and midterm outcomes of patients with cerebral aneurysms treated with Matrix1 and Matrix2 coils: a comparative analysis based on a single-center experience in 250 consecutive cases. Neurosurgery. (2008) 63:1071–7; discussion 1077–9. 10.1227/01.NEU.0000334047.30589.13](https://pubmed.ncbi.nlm.nih.gov/19005397/) 35. [van RooijWJSluzewskiMPelusoJ. In memoriam: the matrix coil. AJNR Am J Neuroradiol. (2014) 35:827–8. 10.3174/ajnr.A3928](https://pubmed.ncbi.nlm.nih.gov/24334404/) 36. [TurkASFiorellaDMoccoJDerdeynC. Counterpoint-response to “in memoriam: the matrix coil”. AJNR Am J Neuroradiol. (2014) 35:828–9. 10.3174/ajnr.A3929](https://pubmed.ncbi.nlm.nih.gov/24334405/) 37. [McDougallCGJohnstonSCHettsSWGholkarABarnwellSLSuarezJCet al. Five-year results of randomized bioactive versus bare metal coils in the treatment of intracranial aneurysms: the Matrix and Platinum Science (MAPS) Trial. J Neurointerv Surg. (2021) 13:930–4. 10.1136/neurintsurg-2020-016906](https://pubmed.ncbi.nlm.nih.gov/33402497/) 38. [RivetDJMoranCJMazumdarAPilgramTKDerdeynCPCrossDT. Single-institution experience with matrix coils in the treatment of intracranial aneurysms: comparison with same-center outcomes with the use of platinum coils. AJNR Am J Neuroradiol. (2007) 28:1736–42. 10.3174/ajnr.A0633](https://pubmed.ncbi.nlm.nih.gov/17923447/) 39. [CognardCWeillASpelleLPiotinMCastaingsLReyA. Long-term angiographic follow-up of 169 intracranial berry aneurysms occluded with detachable coils. Radiology. (1999) 212:348–56. 10.1148/radiology.212.2.r99jl47348](https://pubmed.ncbi.nlm.nih.gov/10429706/) 40. [LeeYJKimDJSuhSHLeeSKKimJKimDI. Stent-assisted coil embolization of intracranial wide-necked aneurysms. Neuroradiology. (2005) 47:680–9. 10.1007/s00234-005-1402-8](https://pubmed.ncbi.nlm.nih.gov/16132800/) 41. [TongFCCloftHJDionJE. Endovascular treatment of intracranial aneurysms with Guglielmi Detachable Coils: emphasis on new techniques. J Clin Neurosci. (2000) 7:244–53. 10.1054/jocn.1999.0211](https://pubmed.ncbi.nlm.nih.gov/10839250/) 42. [MoretJCognardCWeillACastaingsLReyA. The “remodelling technique” in the treatment of wide neck intracranial aneurysms. Angiographic results and clinical follow-up in 56 cases. Interv Neuroradiol. (1997) 3:21–35. 10.1177/159101999700300103](https://pubmed.ncbi.nlm.nih.gov/20678392/) 43. [LevyDI. Embolization of wide-necked anterior communicating artery aneurysm: technical note. Neurosurgery. (1997) 41:979–82. 10.1097/00006123-199710000-00047](https://pubmed.ncbi.nlm.nih.gov/9337500/) 44. [MericleRAWakhlooAKRodriguezRGutermanLRHopkinsLN. Temporary balloon protection as an adjunct to endosaccular coiling of wide-necked cerebral aneurysms: technical note. Neurosurgery. (1997) 41:975–8. 10.1097/00006123-199710000-00045](https://pubmed.ncbi.nlm.nih.gov/9337499/) 45. [CamposJKLienBVWangASLinLM. Advances in endovascular aneurysm management: coiling and adjunctive devices. Stroke Vasc Neurol. (2020) 5:14–21. 10.1136/svn-2019-000303](https://pubmed.ncbi.nlm.nih.gov/32039144/) 46. [WallaceANSamaniegoEKayanYDerdeynCPDelgado AlmandozJEet al. Balloon-assisted coiling of cerebral aneurysms with the dual-lumen Scepter XC balloon catheter: experience at two high-volume centers. Interv Neuroradiol. (2019) 25:414–8. 10.1177/1591019919828677](https://pubmed.ncbi.nlm.nih.gov/30786769/) 47. [DandapatSMendez-RuizAMartínez-GaldámezMMachoJDerakhshaniSTorresGFet al. Review of current intracranial aneurysm flow diversion technology and clinical use. J Neurointerv Surg. (2021) 13:54–62. 10.1136/neurintsurg-2020-015877](https://pubmed.ncbi.nlm.nih.gov/32847929/) 48. [HigashidaRTSmithWGressDUrwinRDowdCFBalousekPAet al. Intravascular stent and endovascular coil placement for a ruptured fusiform aneurysm of the basilar artery. Case report and review of the literature. J Neurosurg. (1997) 87:944–9. 10.3171/jns.1997.87.6.0944](https://pubmed.ncbi.nlm.nih.gov/9384394/) 49. [FiorellaDAlbuquerqueFCHanPMcDougallCG. Preliminary experience using the Neuroform stent for the treatment of cerebral aneurysms. Neurosurgery. (2004) 54:6–16; discussion 16–7. 10.1227/01.neu.0000097194.35781.ea](https://pubmed.ncbi.nlm.nih.gov/14683531/) 50. [WankeIDoerflerASchochBStolkeDForstingM. Treatment of wide-necked intracranial aneurysms with a self-expanding stent system: initial clinical experience. AJNR Am J Neuroradiol. (2003) 24:1192–9.](https://pubmed.ncbi.nlm.nih.gov/14561609/) 51. [KadkhodayanYRhodesNBlackburnSDerdeynCP. Cross 3rd DT, Moran CJ. Comparison of Enterprise with Neuroform stent-assisted coiling of intracranial aneurysms. AJR Am J Roentgenol. (2013) 200:872–8. 10.2214/AJR.12.8954](https://pubmed.ncbi.nlm.nih.gov/23520120/) 52. [CarrollWMKellyMJ. Corrosion behavior of nitinol wires in body fluid environments. J Biomed Mater Res A. (2003) 67:1123–30. 10.1002/jbm.a.10099](https://pubmed.ncbi.nlm.nih.gov/14624475/) 53. [HigashidaRTHalbachVVDowdCFJuravskyLMeagherS. Initial clinical experience with a new self-expanding nitinol stent for the treatment of intracranial cerebral aneurysms: the Cordis Enterprise stent. AJNR Am J Neuroradiol. (2005) 26:1751–6.](https://pubmed.ncbi.nlm.nih.gov/16230553/) 54. [DuEHYShankarJJSLVISJr. 'shelf' technique: an alternative to Y stent-assisted aneurysm coiling. J Neurointerv Surg. (2016) 8:1256–9. 10.1136/neurintsurg-2015-012246](https://pubmed.ncbi.nlm.nih.gov/26449710/) 55. [UlfertCPhamMSonnbergerMAmayaFTrenklerJBendszusMet al. The Neuroform Atlas stent to assist coil embolization of intracranial aneurysms: a multicentre experience. J Neurointerv Surg. (2018) 10:1192–6. 10.1136/neurintsurg-2017-013516](https://pubmed.ncbi.nlm.nih.gov/29196482/) 56. [BroadbentLPMoranCJCross 3rdDTDerdeynCP. Management of neuroform stent dislodgement and misplacement. AJNR Am J Neuroradiol. (2003) 24:1819–22.](https://pubmed.ncbi.nlm.nih.gov/14561619/) 57. [ChowMMWooHHMasarykTJRasmussenPA. A novel endovascular treatment of a wide-necked basilar apex aneurysm by using a Y-configuration, double-stent technique. AJNR Am J Neuroradiol. (2004) 25:509–12.](https://pubmed.ncbi.nlm.nih.gov/15037568/) 58. [KimDChungJ. Y-stent-assisted coiling with Neuroform Atlas stents for wide-necked intracranial bifurcation aneurysms: a preliminary report. J Cerebrovasc Endovasc Neurosurg. (2022) 24:1–9. 10.7461/jcen.2021.E2021.06.010](https://pubmed.ncbi.nlm.nih.gov/35299236/) 59. [BlackburnSLKadkhodayanYShekhtmanEDerdeynCPCross 3rdDTMoranCJ. Treatment of basilar tip aneurysms with horizontal PCA to PCA stent-assisted coiling: case series. J Neurointerv Surg. (2013) 5:212–6. 10.1136/neurintsurg-2012-010301](https://pubmed.ncbi.nlm.nih.gov/22535894/) 60. [AydinKStrackeCPBarburogluMYamacEBerdikhojayevMSencerSet al. Long-term outcomes of wide-necked intracranial bifurcation aneurysms treated with T-stent-assisted coiling. J Neurosurg. (2019) 2019:1–10. 10.3171/2019.9.JNS191733](https://pubmed.ncbi.nlm.nih.gov/31783344/) 61. [SaatciIGeyikSYavuzKCekirgeS. X-configured stent-assisted coiling in the endovascular treatment of complex anterior communicating artery aneurysms: a novel reconstructive technique. AJNR Am J Neuroradiol. (2011) 32:E113–7. 10.3174/ajnr.A2111](https://pubmed.ncbi.nlm.nih.gov/21393414/) 62. [CrossDT3rdMoranCJDerdeynCPMazumdarARivetDChicoineMM. Neuroform stent deployment for treatment of a basilar tip aneurysm via a posterior communicating artery route. AJNR Am J Neuroradiol. (2005) 26:2578–81.](https://pubmed.ncbi.nlm.nih.gov/16230567/) 63. [QuintanaEMValdesPVDezaEMGarcíaAGRodríguezMCPérezJMJet al. Initial experience and one-year follow-up with Neuroform Atlas Stent System for the treatment of brain aneurysms. Interv Neuroradiol. (2019) 25:521–9. 10.1177/1591019918819087](https://pubmed.ncbi.nlm.nih.gov/30563304/) 64. [GoryBSpiottaAMMangiaficoSConsoliABiondiAPomeroEet al. PulseRider stent-assisted coiling of wide-neck bifurcation aneurysms: periprocedural results in an international series. AJNR Am J Neuroradiol. (2016) 37:130–5. 10.3174/ajnr.A4506](https://pubmed.ncbi.nlm.nih.gov/26381338/) 65. [ArthurASMolyneuxACoonALSaatciISzikoraIBaltaciogluFet al. The safety and effectiveness of the Woven EndoBridge (WEB) system for the treatment of wide-necked bifurcation aneurysms: final 12-month results of the pivotal WEB Intrasaccular Therapy (WEB-IT) Study. J Neurointerv Surg. (2019) 11:924–30. 10.1136/neurintsurg-2019-014815](https://pubmed.ncbi.nlm.nih.gov/31189679/) 66. [SorensonTJIacobucciMMuradMHSpelleLMoretJLanzinoG. The pCONUS bifurcation aneurysm implants for endovascular treatment of adults with intracranial aneurysms: a systematic review and meta-analysis. Surg Neurol Int. (2019) 10:24. 10.4103/sni.sni_297_18](https://pubmed.ncbi.nlm.nih.gov/30881640/) 67. [PranataRYonasEVaniaRSidipratomoPJulyJ. Efficacy and safety of PulseRider for treatment of wide-necked intracranial aneurysm—a systematic review and meta-analysis. Interv Neuroradiol. (2021) 27:60–7. 10.1177/1591019920940521](https://pubmed.ncbi.nlm.nih.gov/32631244/) 68. [BehzadiFHeifermanDMWozniakAAfrickBBallardMChazaroJet al. Comparison of transarterial n-BCA and Onyx embolization of brain arteriovenous malformations: a single-center 18-year retrospective analysis. J Cerebrovasc Endovasc Neurosurg. (2022) 24:144–53. 10.7461/jcen.2022.E2021.12.003](https://pubmed.ncbi.nlm.nih.gov/35299239/) 69. [TakiWNishiSYamashitaKSadatohANakaharaIKikuchiHet al. Selection and combination of various endovascular techniques in the treatment of giant aneurysms. J Neurosurg. (1992) 77:37–42. 10.3171/jns.1992.77.1.0037](https://pubmed.ncbi.nlm.nih.gov/1602330/) 70. [MandaiSKinugasaKOhmotoT. Direct thrombosis of aneurysms with cellulose acetate polymer. Part II: Preliminary clinical experience. J Neurosurg. (1992) 77:501–7. 10.3171/jns.1992.77.4.0501](https://pubmed.ncbi.nlm.nih.gov/1326490/) 71. [ChaloupkaJCGuglielmiGVinuelaF. Direct thrombosis of aneurysms. J Neurosurg. (1993) 78:1006–8. 10.3171/jns.1993.78.6.1006](https://pubmed.ncbi.nlm.nih.gov/8487184/) 72. [MurayamaYVinuelaFTateshimaSVinuela FJrAkibaY. Endovascular treatment of experimental aneurysms by use of a combination of liquid embolic agents and protective devices. AJNR Am J Neuroradiol. (2000) 21:1726–35.](https://pubmed.ncbi.nlm.nih.gov/11039347/) 73. [MolyneuxAJCekirgeSSaatciIGalG. Cerebral Aneurysm Multicenter European Onyx (CAMEO) trial: results of a prospective observational study in 20 European centers. AJNR Am J Neuroradiol. (2004) 25:39–51.](https://pubmed.ncbi.nlm.nih.gov/14729687/) 74. [CekirgeHSSaatciIOzturkMHCilBAratAMawadMet al. Late angiographic and clinical follow-up results of 100 consecutive aneurysms treated with Onyx reconstruction: largest single-center experience. Neuroradiology. (2006) 48:113–26. 10.1007/s00234-005-0007-6](https://pubmed.ncbi.nlm.nih.gov/16400462/) 75. [RahmeRGrandeAJimenezLAbruzzoTARingerAJ. Onyx HD-500 embolization of intracranial aneurysms: modified technique using continuous balloon inflation under conscious sedation. J Clin Neurosci. (2014) 21:1383–7. 10.1016/j.jocn.2014.01.004](https://pubmed.ncbi.nlm.nih.gov/24630460/) 76. [VanentKNFedericoEMBassDIBarrosGKeenJLevittMR. Nickels and tines: the myth of nickel allergy in intracranial stents. J Neurointerv Surg. (2022) 14:403–7. 10.1136/neurintsurg-2021-018365](https://pubmed.ncbi.nlm.nih.gov/34784742/) 77. [DalyaiRTRandazzoCGhobrialGGonzalezLFTjoumakarisSIDumontASet al. Redefining onyx HD 500 in the flow diversion era. Int J Vasc Med. (2012) 2012:435490. 10.1155/2012/435490](https://pubmed.ncbi.nlm.nih.gov/22611438/) 78. [D'UrsoPILanzinoGCloftHJKallmesDF. Flow diversion for intracranial aneurysms: a review. Stroke. (2011) 42:2363–8. 10.1161/STROKEAHA.111.620328](https://pubmed.ncbi.nlm.nih.gov/21778426/) 79. [CrowleyRWEvansAJKassellNFJensenMEDumontAS. Endovascular treatment of a fusiform basilar artery aneurysm using multiple “in-stent stents”. Technical note J Neurosurg Pediatr. (2009) 3:496–500. 10.3171/2009.2.PEDS08468](https://pubmed.ncbi.nlm.nih.gov/19480540/) 80. [IonitaCNPaciorekAMHoffmannKRBednarekDRYamamotoJKolegaJet al. Asymmetric vascular stent: feasibility study of a new low-porosity patch-containing stent. Stroke. (2008) 39:2105–13. 10.1161/STROKEAHA.107.503862](https://pubmed.ncbi.nlm.nih.gov/18483329/) 81. [SadasivanCCesarLSeongJRakianAHaoQTioFOet al. An original flow diversion device for the treatment of intracranial aneurysms: evaluation in the rabbit elastase-induced model. Stroke. (2009) 40:952–8. 10.1161/STROKEAHA.108.533760](https://pubmed.ncbi.nlm.nih.gov/19164777/) 82. [KulcsarZWetzelSGAugsburgerLGruberAWankeIRufenachtDA. Effect of flow diversion treatment on very small ruptured aneurysms. Neurosurgery. (2010) 67:789–93. 10.1227/01.NEU.0000372920.39101.55](https://pubmed.ncbi.nlm.nih.gov/20736834/) 83. [LylykPMirandaCCerattoRFerrarioAScrivanoELunaHRet al. Curative endovascular reconstruction of cerebral aneurysms with the pipeline embolization device: the Buenos Aires experience. Neurosurgery. (2009) 64:632–42; discussion 642–3; quiz N6. 10.1227/01.NEU.0000339109.98070.65](https://pubmed.ncbi.nlm.nih.gov/19295373/) 84. [BecskeTKallmesDFSaatciIMcDougallCGSzikoraILanzinoGet al. Pipeline for uncoilable or failed aneurysms: results from a multicenter clinical trial. Radiology. (2013) 267:858–68. 10.1148/radiol.13120099](https://pubmed.ncbi.nlm.nih.gov/23525615/) 85. [CloftHJ. Flow diversion for cerebral aneurysms: a cautionary tale. AJNR Am J Neuroradiol. (2011) 32:26. 10.3174/ajnr.A2373](https://pubmed.ncbi.nlm.nih.gov/21193557/) 86. [CloftHJ. What is all of the hype about?AJNR Am J Neuroradiol. (2008) 29:1604. 10.3174/ajnr.A1228](https://pubmed.ncbi.nlm.nih.gov/18784223/) 87. [KallmesDFBrinjikjiWCekirgeSFiorellaDHanelRAJabbourPet al. Safety and efficacy of the Pipeline embolization device for treatment of intracranial aneurysms: a pooled analysis of 3 large studies. J Neurosurg. (2017) 127:775–80. 10.3171/2016.8.JNS16467](https://pubmed.ncbi.nlm.nih.gov/27837809/) 88. [PatelPDChalouhiNAtallahETjoumakarisSHasanDZarzourHet al. Off-label uses of the Pipeline embolization device: a review of the literature. Neurosurg Focus. (2017) 42:E4. 10.3171/2017.3.FOCUS1742](https://pubmed.ncbi.nlm.nih.gov/28366030/) 89. [LeungGKTsangACLuiWM. Pipeline embolization device for intracranial aneurysm: a systematic review. Clin Neuroradiol. (2012) 22:295–303. 10.1007/s00062-012-0178-6](https://pubmed.ncbi.nlm.nih.gov/22821268/) 90. [PereiraVMKellyMVegaPMuriasEYilmazHErcegGet al. New pipeline flex device: initial experience and technical nuances. J Neurointerv Surg. (2015) 7:920–5. 10.1136/neurintsurg-2014-011347](https://pubmed.ncbi.nlm.nih.gov/25605707/) 91. [Martínez-GaldámezMLaminSMLagiosKGLiebigTCiceriEFChapotRet al. Treatment of intracranial aneurysms using the pipeline flex embolization device with shield technology: angiographic and safety outcomes at 1-year follow-up. J Neurointerv Surg. (2019) 11:396–9. 10.1136/neurintsurg-2018-014204](https://pubmed.ncbi.nlm.nih.gov/30404766/) 92. [MausVWeberWBerlisAMaurerCFischerS. Initial experience with surpass evolve flow diverter in the treatment of intracranial aneurysms. Clin Neuroradiol. (2021) 31:681–9. 10.1007/s00062-020-00972-5](https://pubmed.ncbi.nlm.nih.gov/33420947/) 93. [DiazOGistTLManjarezGOrozcoFAlmeidaR. Treatment of 14 intracranial aneurysms with the FRED system. J Neurointerv Surg. (2014) 6:614–7. 10.1136/neurintsurg-2013-010917](https://pubmed.ncbi.nlm.nih.gov/24334405/) 94. [MöhlenbruchMAKizilkilicOKiller-OberpfalzerMBaltaciogluFIslakCBendszusMet al. Multicenter experience with FRED Jr flow re-direction endoluminal device for intracranial aneurysms in small arteries. AJNR Am J Neuroradiol. (2017) 38:1959–65. 10.3174/ajnr.A5332](https://pubmed.ncbi.nlm.nih.gov/28774846/) 95. [GavrilovicVDapotoAMarottiNPellegrinAPauroAVitAet al. Silk vista baby is a safe and technically feasible flow diverting stent for distal aneurysm treatment. Front Neurol. (2021) 12:676749. 10.3389/fneur.2021.676749](https://pubmed.ncbi.nlm.nih.gov/34093322/) 96. [Valle-GilerEPAtallahETjoumakarisSRosenwasserRHJabbourP. Transcirculation pipeline embolization device deployment: a rescue technique. Neurosurg Focus. (2017) 42:E13. 10.3171/2017.2.FOCUS16485](https://pubmed.ncbi.nlm.nih.gov/28366039/) 97. [ColbyGPLinLMHuangJTamargoRJCoonAL. Utilization of the Navien distal intracranial catheter in 78 cases of anterior circulation aneurysm treatment with the Pipeline embolization device. J Neurointerv Surg. (2013) 5 Suppl3:iii16–21. 10.1136/neurintsurg-2013-010692](https://pubmed.ncbi.nlm.nih.gov/23964049/) 98. [TopcuogluOMAratAPekerASarikayaB. Intermediate catheter placement distal to the cerebral aneurysm during flow diversion embolization with the Surpass device. J Neurointerv Surg. (2018) 10:e35. 10.1136/neurintsurg-2017-013662](https://pubmed.ncbi.nlm.nih.gov/29196483/) 99. [HauckEFTawkRGKarterNSBinningMJKhalessiAANatarajanSKet al. Use of the outreach distal access catheter as an intracranial platform facilitates coil embolization of select intracranial aneurysms: technical note. J Neurointerv Surg. (2011) 3:172–6. 10.1136/jnis.2010.002535](https://pubmed.ncbi.nlm.nih.gov/21990209/) 100. [LauzierDCClerSJOsbunJWChatterjeeARMoranCJKansagraAP. The value of long-term angiographic follow-up following pipeline embolization of intracranial aneurysms. J Neurointerv Surg. (2021). 10.1136/neurintsurg-2021-017745](https://pubmed.ncbi.nlm.nih.gov/34784742/) 101. [SambuNCurzenN. Monitoring the effectiveness of antiplatelet therapy: opportunities and limitations. Br J Clin Pharmacol. (2011) 72:683–96. 10.1111/j.1365-2125.2011.03955.x](https://pubmed.ncbi.nlm.nih.gov/21480924/) 102. [BecskeTBrinjikjiWPottsMBKallmesDFShapiroMMoranCJet al. Long-term clinical and angiographic outcomes following pipeline embolization device treatment of complex internal carotid artery aneurysms: five-year results of the pipeline for uncoilable or failed aneurysms trial. Neurosurgery. (2017) 80:40–8. 10.1093/neuros/nyw014](https://pubmed.ncbi.nlm.nih.gov/27837809/) 103. [BrigantiFLeoneGMarsegliaMMarinielloGCaranciFBrunettiAet al. Endovascular treatment of cerebral aneurysms using flow-diverter devices: a systematic review. Neuroradiol J. (2015) 28:365–75. 10.1177/1971400915602803](https://pubmed.ncbi.nlm.nih.gov/26381338/) 104. [KlischJSychraVStrasillaCLiebigTFiorellaD. The Woven EndoBridge cerebral aneurysm embolization device (WEB II): initial clinical experience. Neuroradiology. (2011) 53:599–607. 10.1007/s00234-011-0891-x](https://pubmed.ncbi.nlm.nih.gov/21626330/) 105. [DmytriwAADibasMGhozySAdeebNDiestroJDPhanKet al. The Woven EndoBridge (WEB) device for the treatment of intracranial aneurysms: ten years of lessons learned and adjustments in practice from the WorldWideWEB Consortium. Transl Stroke Res. (2022) 2022:1–10. 10.1007/s12975-022-01072-x](https://pubmed.ncbi.nlm.nih.gov/35790899/) 106. [Youssef PP IiiDDPetersonJSweidAZakeriANimjeeSMet al. Woven EndoBridge (WEB) device in the treatment of ruptured aneurysms. J Neurointerv Surg. (2021) 13:443–6. 10.1136/neurintsurg-2020-016405](https://pubmed.ncbi.nlm.nih.gov/32631244/) 107. [HaffafIClarençonFShotarERolla-BiglianiCPerreSVMathonBet al. Medina embolization device for the treatment of intracranial aneurysms: 18 months' angiographic results. J Neurointerv Surg. (2019) 11:516–22. 10.1136/neurintsurg-2018-014110](https://pubmed.ncbi.nlm.nih.gov/30404766/) 108. [DingYHLewisDAKadirvelRDaiDKallmesDF. The Woven EndoBridge: a new aneurysm occlusion device. AJNR Am J Neuroradiol. (2011) 32:607–11. 10.3174/ajnr.A2399](https://pubmed.ncbi.nlm.nih.gov/21393414/) 109. [MouchtourisNHasanDSamaniegoEASaieghFASweidAAbbasRet al. The Woven EndoBridge (WEB) device: feasibility, techniques, and outcomes after FDA approval. J Neurosurg. (2021) 2021:1–7. 10.3171/2021.5.JNS21889](https://pubmed.ncbi.nlm.nih.gov/34784742/) 110. [GoyalNHoitDDiNittoJElijovichLFiorellaDPierotLet al. How to WEB: a practical review of methodology for the use of the Woven EndoBridge. J Neurointerv Surg. (2020) 12:512–20. 10.1136/neurintsurg-2019-015506](https://pubmed.ncbi.nlm.nih.gov/31904832/) 111. [BiondiAPrimikirisPVitaleGCharbonnierG. Endosaccular flow disruption with the Contour Neurovascular System: angiographic and clinical results in a single-center study of 60 unruptured intracranial aneurysms. J Neurointerv Surg. (2022). 10.1136/jnis-2022-019271. [Epub ahead of print].](https://pubmed.ncbi.nlm.nih.gov/35790899/) 112. [BhogalPUdaniSCognardCPiotinMBrouwerPSourourN-Aet al. Endosaccular flow disruption: where are we now?J Neurointerv Surg. (2019) 11:1024–5. 10.1136/neurintsurg-2018-014623](https://pubmed.ncbi.nlm.nih.gov/30404766/) 113. [FarrokhSOwusuKLaraLRNaultKHuiFSpoelhofB. Neuro-interventional use of oral antiplatelets: a survey of neuro-endovascular centers in the United States and review of the literature. J Pharm Pract. (2021) 34:207–15. 10.1177/0897190019854868](https://pubmed.ncbi.nlm.nih.gov/31189679/) 114. [ChoiHHChoYDHanMHChoW-SKimJELeeJJet al. Antiplatelet premedication-free stent-assisted coil embolization in acutely ruptured aneurysms. World Neurosurg. (2018) 114:e1152–60. 10.1016/j.wneu.2018.03.164](https://pubmed.ncbi.nlm.nih.gov/29574170/) 115. [DeloraAEzzeldinOAliUEl-GhanemMEzzeldinM. Ultra-short-term dual antiplatelet therapy in treating unruptured brain aneurysm with the pipeline flex-shield embolization device. Cureus. (2022) 14:e25516. 10.7759/cureus.25516](https://pubmed.ncbi.nlm.nih.gov/35790899/) 116. [EdwardsNJJonesWHSanzgiriACoronaJDannenbaumMChenPR. Antiplatelet therapy for the prevention of peri-coiling thromboembolism in high-risk patients with ruptured intracranial aneurysms. J Neurosurg. (2017) 127:1326–32. 10.3171/2016.9.JNS161340](https://pubmed.ncbi.nlm.nih.gov/27837809/) 117. [AbecassisIJSainiVCrowleyRWMunichSASingerJOsbunJWet al. The Rist radial access system: a multicenter study of 152 patients. J Neurointerv Surg. (2022) 14:403–7. 10.1136/neurintsurg-2021-017739](https://pubmed.ncbi.nlm.nih.gov/34784742/) 118. [HarlandTASeinfeldJWhiteACKumpeDARoarkCDCaseDE. Comparative analysis of unruptured cerebral aneurysm treatment outcomes and complications with the classic versus flex pipeline embolization devices and phenom versus marksman microcatheter delivery system: the role of microcatheter choice on complication rate. J Vasc Interv Neurol. (2020) 11:13–8.](https://pubmed.ncbi.nlm.nih.gov/32631244/) 119. [AkbariSHReynoldsMRKadkhodayanYCross DT3rdMoranCJ. Hemorrhagic complications after prasugrel (Effient) therapy for vascular neurointerventional procedures. J Neurointerv Surg. (2013) 5:337–43. 10.1136/neurintsurg-2012-010334](https://pubmed.ncbi.nlm.nih.gov/22535894/) 120. [CaroffJAubertLLavenu-BombledCFigueiredoSHabchiKCorteseJet al. Antithrombotic therapies for neurointerventional surgery: a 2021 French comprehensive national survey. J Neurointerv Surg. (2022) 4:402–7. 10.1136/neurintsurg-2021-018601](https://pubmed.ncbi.nlm.nih.gov/34784742/) 121. [LauzierDCClerSJOsbunJWChatterjeeARMoranCJKansagraAP. Management of in-stent stenosis with dual antiplatelet therapy following pipeline embolization of intracranial aneurysms. World Neurosurg. (2022) 167:e303–e309. 10.1016/j.wneu.2022.08.002](https://pubmed.ncbi.nlm.nih.gov/35790899/) 122. [LauzierDCClerSJKansagraAP. Examining the value of neurointerventional follow-up. World Neurosurg. (2021) 155:191–2. 10.1016/j.wneu.2021.08.059](https://pubmed.ncbi.nlm.nih.gov/34784742/) 123. [KaufmannTJHustonJ3rdMandrekarJNSchleckCDThielenKRKallmesDF. Complications of diagnostic cerebral angiography: Evaluation of 19,826 consecutive patients. Radiology. (2007) 243:812–9. 10.1148/radiol.2433060536](https://pubmed.ncbi.nlm.nih.gov/17517926/) 124. [LaurentDLucke-WoldBDoddWSMartinezMChowdhuryMABHosakaKet al. Combination release of chemokines from coated coils to target aneurysm healing. J Neurointerv Surg. (2022). 10.1136/jnis-2022-018710. [Epub ahead of print].](https://pubmed.ncbi.nlm.nih.gov/35790899/) 125. [HosakaKRojasKFazalHZSchneiderMBShoresJFedericoVet al. Monocyte chemotactic protein-1-interleukin-6-osteopontin pathway of intra-aneurysmal tissue healing. Stroke. (2017) 48:1052–60. 10.1161/STROKEAHA.116.015590](https://pubmed.ncbi.nlm.nih.gov/28270484/)